TrialDrug design, development and therapy2015

Randomized, open-label, blinded-endpoint, crossover, single-dose study to compare the pharmacodynamics of torasemide-PR 10 mg, torasemide-IR 10 mg, and furosemide-IR 40 mg, in patients with chronic heart failure.

Maria Rosa Ballester et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.